Retina 2022 - 46º Congresso da Sociedade Brasileira de Retina e Vítreo
  1. Home

Program

Filter activities
BRAVS ROOM
09:00 - 09:48
Retina Start

RETINA START

09:00 - 09:03
Medical Case 1 - 17291 - DENGUE MACULOPATHY
09:03 - 09:06
Discussion
09:06 - 09:09
Medical Case 2 - 17222 - SPONTANEOUS RETINAL REATTACHMENT AFTER A 300-DEGREE GIANT RETINAL TEAR IN A CHILD WITH STICKLER SYNDROME.
09:09 - 09:12
Discussion
09:12 - 09:15
Medical Case 3 - 17277 - TORPEDO MACULOPATHY
09:15 - 09:18
Discussion
09:18 - 09:21
Medical Case 4 - 17272 - Ocular manifestations of vertical transmission of dengue: case report
09:21 - 09:24
Discussion
09:24 - 09:27
Surgical Case 1 - 17216 - PNEUMATIC RETINOPEXY AND LASER PHOTOCOAGULATION FOR MACULAR RETINAL DETACHMENT SECONDARY TO OPTIC DISC COLOBOMA
09:27 - 09:30
Discussion
09:30 - 09:33
Surgical Case 2 - 17221 - INTRAOPERATIVE OCT AND COMPLEX DIABETIC RETINOPATHY DETACHMENT
09:33 - 09:36
Discussion
09:36 - 09:39
Surgical Case 3 - 17225 - SURGICAL MANAGEMENT OF RECURRENT RETINAL DETACHMENT
09:39 - 09:42
Discussion
09:42 - 09:45
Surgical Case 4 - 17273 - PHACOVITRECTOMY ON HIGH MYOPIC PATIENT + ERM PEEL + ICL REMOVAL
09:45 - 09:48
Discussion
BRAVS ROOM
09:48 - 10:36
Retina Pink

RETINA PINK

09:48 - 09:51
Mystery case
09:51 - 09:54
Discussion
09:54 - 09:57
Mystery case
09:57 - 10:00
Discussion
10:00 - 10:03
Mystery case
10:03 - 10:06
Discussion
10:06 - 10:09
Mystery case
10:09 - 10:12
Discussion
10:12 - 10:15
Mystery case
10:15 - 10:18
Discussion
10:18 - 10:21
Mystery case
10:21 - 10:24
Discussion
10:24 - 10:27
Mystery case
10:27 - 10:30
Discussion
10:30 - 10:33
Mystery case
10:33 - 10:36
Discussion
BRAVS ROOM
10:36 - 11:05
Symposium

BRAVS Advocacy & Practice

10:36 - 10:40
Abertura
10:40 - 10:45
Por que devo me envolver com Defesa de Classe
10:45 - 10:50
Mudança no estatuto da BRAVS: Defesa Profissional
10:50 - 10:55
Ações da BRAVS junto ao Governo Federal / Anvisa / MS
10:55 - 11:00
Ações contra entrega direta de insumos as clínicas : SCO/BRAVS/CBO X Unimed Mercosul
11:00 - 11:05
Certificação / Avaliação de programa de Fellowship em Retina
BRAVS ROOM
11:05 - 12:05
Break Symposium

BREAK SYMPOSIUM BAYER: MACULA IN FOCUS

11:05 - 11:08
Welcome & Bayer commitment in ophthalmology
11:08 - 11:10
Opening Session
11:10 - 11:18
Clinical case of durability in DME
11:18 - 11:26
Clinical case of T&E regime in wAMD
11:26 - 11:34
Clinical case in RVO
11:34 - 11:42
Surgical case in retinopathy
11:42 - 11:50
Gene therapy in retinal diseases
11:50 - 11:52
Final considerations & closing
BRAVS ROOM
12:05 - 13:41
Surgical Case

BRAVS CHALLENGING SURGICAL CASES

12:05 - 12:08
Mystery case
12:08 - 12:11
Discussion
12:11 - 12:14
Mystery case
12:14 - 12:17
Discussion
12:17 - 12:20
Mystery case
12:20 - 12:23
Discussion
12:23 - 12:26
Mystery case
12:26 - 12:29
Discussion
12:29 - 12:32
Mystery case
12:32 - 12:35
Discussion
12:35 - 12:38
Mystery case
12:38 - 12:41
Discussion
12:41 - 12:44
Mystery case
12:44 - 12:47
Discussion
12:47 - 12:50
Mystery case
12:50 - 12:53
Discussion
12:53 - 12:56
Mystery case
12:56 - 12:59
Discussion
12:59 - 13:02
Mystery case
13:02 - 13:05
Discussion
13:05 - 13:08
Mystery case
13:08 - 13:11
Discussion
13:11 - 13:14
Mystery case
13:14 - 13:17
Discussion
13:17 - 13:20
Mystery case
13:20 - 13:23
Discussion
13:23 - 13:26
Mystery case
13:26 - 13:29
Discussion
13:29 - 13:32
Mystery case
13:32 - 13:35
Discussion
13:35 - 13:38
Mystery case
13:38 - 13:41
Discussion
BRAVS ROOM
13:41 - 14:41
Lunch Break

LUNCH

BRAVS ROOM
14:41 - 16:17
Medical Case

BRAVS CHALLENGING MEDICAL CASES

14:41 - 14:44
Mystery case
14:44 - 14:47
Discussion
14:47 - 14:50
Mystery case
14:50 - 14:53
Discussion
14:53 - 14:56
Mystery case
14:56 - 14:59
Discussion
14:59 - 15:02
Mystery case
15:02 - 15:05
Discussion
15:05 - 15:08
Mystery case
15:08 - 15:11
Discussion
15:11 - 15:14
Mystery case
15:14 - 15:17
Discussion
15:17 - 15:20
Mystery case
15:20 - 15:23
Discussion
15:23 - 15:26
Mystery case
15:26 - 15:29
Discussion
15:29 - 15:32
Mystery case
15:32 - 15:35
Discussion
15:35 - 15:38
Mystery case
15:38 - 15:41
Discussion
15:41 - 15:44
Mystery case
15:44 - 15:47
Discussion
15:47 - 15:50
Mystery case
15:50 - 15:53
Discussion
15:53 - 15:56
Mystery case
15:56 - 15:59
Discussion
15:59 - 16:02
Mystery case
16:02 - 16:05
Discussion
16:05 - 16:08
Mystery case
16:08 - 16:11
Discussion
16:11 - 16:14
Mystery case
16:14 - 16:17
Discussion
BRAVS ROOM
16:17 - 17:17
Break Symposium

BREAK SYMPOSIUM - ALCON

BRAVS ROOM
17:17 - 18:16
Symposium

BRAVS UPDATE SYMPOSIUM IRD & GENETICS

17:17 - 17:25
Distrofias retinianas no Brasil
17:25 - 17:33
Experiência Real World em RPE65 e panorama de outros estudos clínicos
17:33 - 17:41
O que o retinólogo não geneticista precisa saber?
17:41 - 17:49
Como acompanhar o paciente com distrofia retiniana
17:49 - 17:57
Desafios cirúrgicos em terapia gênica retiniana
17:57 - 18:05
Terapia gênica em doenças retinianas prevalentes
18:05 - 18:16
Perguntas
BRAVS ROOM
18:16 - 18:52
Free Papers

BEST OF BRAVS

18:16 - 18:18
Best BRAVS Image – Jaco Lavinsky Award - Double Peel ERM & ILM Severe Proliferative Diabetic Retinopathy Unveilled Macular Hole & OCT
18:18 - 18:20
Best BRAVS Tube – Andre M V Gomes Award - Injeção sub-retiniana de BSS para tratamento de prega macular em vitreorretinopatia exaudativa familiar
18:20 - 18:22
Best Clinical Case Report Poster – Suel Abujamra Award - 17223 - RETINAL CHANGES IN CONGENITAL ZIKA SYNDROME: 1-YEAR FOLLOW-UP
18:22 - 18:24
Best Surgical Case Report Poster - Oswaldo Moura Brasil Award – 17275 - AVALIAÇAO DA ACUIDADE VISUAL POS-OPERATORIA POR DESCOLAMENTO DE RETINA REGMATOGENICO EM FEIRA DE SANTANA – BA
18:26 - 18:28
Best BRAVS Free Paper – Marcos Avila Award - 17245 - LIPOSOME-ENCAPSULATED VANCOMYCIN FOR ENDOPHTHALMITIS TREATMENT IN RABBIT EYESCTOR THERAPY FOR DIABETIC MACULAR EDEMA
18:28 - 18:30
Best Innovative Research Free Paper – Mario Motta Award - 17243 - USE OF A SLOW-RELEASE INTRAVITREAL CLINDAMYCIN IMPLANT FOR THE MANAGEMENT OF OCULAR TOXOPLASMOSIS: A PHASE I CLINICAL TRIAL
18:30 - 18:32
Best Clinical Free Paper – Walter Takahashi Award - 17242 - SAFETY OF INTRAVITREAL METOPROLOL IN EYES WITH CENTRAL SEROUS CHORIORETINOPATHY
18:32 - 18:34
Best Surgical Free Paper – Marcio Nehemy Award - 17187 - A COMPARISON OF JUNIOR AND SENIOR VITREORETINAL SURGEON PERFORMANCE ON A SURGICAL SIMULATOR FOLLOWING CAFFEINE, Β-BLOCKERS, OR BOTH
18:34 - 18:36
Best Experimental Free Paper – Roberto Abdalla Moura Award - 17245 - LIPOSOME-ENCAPSULATED VANCOMYCIN FOR ENDOPHTHALMITIS TREATMENT IN RABBIT EYES
18:36 - 18:38
Best BRAVS Video – Hisashi Suzuki Award - 17229 - Traumatic closed-funnel retinal detachment associated with pseudophacocele
18:38 - 18:40
Best Video Innovation – Joviano de Rezende Filho Award - 17206 - Subretinal fluid injection to close a refractory full-thickness macular hole
18:40 - 18:42
Best Video Complication – Francisco Arthur Mais Award - 17208 - SURGICAL MANAGEMENT OF RECURRENT RETINAL DETACHMENT
18:42 - 18:44
Best Video Challenging Surgery – Sergio Cunha Award - 17247 - PVD induction - not so easy
18:44 - 18:46
Best Video Education – Luiz de Assumpção Osório Award - 17228 - TRACTION RETINAL DETACHMENT REPAIR : STEP BY STEP
18:46 - 18:48
Best Video Young Surgeon – Christiano Barsante Award - 17274 - The Beauty of Scleral Buckling: Tips and Pitfalls
BRAVS ROOM
18:52 - 19:07
International Lecture

INTERNATIONAL LECTURES 01

18:52 - 19:07
Traditional, optical and liquid biopsies in ophthalmology
BRAVS ROOM
19:07 - 19:37
Opening Ceremony

OPENING CEREMONY

BRAVS ROOM
07:00 - 08:00
Assembly

BRAVS ASSEMBLY

BRAVS ROOM
08:15 - 08:44
Bravs Lecture

BRAVS LECTURE 01

08:20 - 08:44
Tratamento da coroidopatia central serosa
BRAVS ROOM
08:44 - 09:11
International Lecture

INTERNATIONAL LECTURES 02

08:44 - 08:53
Ang2 inhibition for AMD
08:53 - 09:02
Geographic Atrophy Drug in the pipeline
09:02 - 09:11
Dietary Supplements & Dietary Patterns in AMD
BRAVS ROOM
09:11 - 10:23
Panel

BRAVS PANEL 01 – MEDICAL RETINA

09:11 - 09:15
AMD#1
09:15 - 09:20
Discussion
09:20 - 09:24
AMD#2
09:24 - 09:29
Discussion
09:29 - 09:33
Diabetic retinopathy#1
09:33 - 09:38
Discussion
09:38 - 09:42
Diabetic retinopathy#2
09:42 - 09:47
Discussion
09:47 - 09:51
Retinal vascular disease#1
09:51 - 09:56
Discussion
09:56 - 10:00
Retinal vascular disease#2
10:00 - 10:05
Discussion
10:05 - 10:09
Maculopathy#1
10:09 - 10:14
Discussion
10:14 - 10:18
Maculopathy#2
10:18 - 10:23
Discussion
BRAVS ROOM
10:23 - 11:23
Break Symposium

BREAK SYMPOSIUM BAYER: PUBLIC HEALTH: CHALLENGES AND OPPORTUNITIES IN THE TREATMENT OF RETINAL DISEASES

10:23 - 10:28
Opening
10:28 - 10:38
Patient’s perspective
10:38 - 10:48
Medical responsibility and its challenges
10:48 - 10:53
Medical Society’s commitment in public health policies
BRAVS ROOM
11:23 - 11:50
International Lecture

INTERNATIONAL LECTURES 03

11:23 - 11:32
Tips and Tricks in Secondary IOL'S
11:32 - 11:41
New Toys 4Us
11:41 - 11:50
Endoscopy for Severe Eye Trauma
BRAVS ROOM
11:50 - 13:02
Panel

BRAVS PANEL 02 – SURGICAL RETINA

11:50 - 11:54
Macular surgery#1
11:54 - 11:59
Discussion
11:59 - 12:03
Macular surgery#2
12:03 - 12:08
Discussion
12:08 - 12:12
Retinal detachment#1
12:12 - 12:17
Discussion
12:17 - 12:21
Retinal detachment#2
12:21 - 12:26
Discussion
12:26 - 12:30
Diabetic vitrectomy#1
12:30 - 12:35
Discussion
12:35 - 12:39
Diabetic vitrectomy#2
12:39 - 12:44
Discussion
12:44 - 12:48
Trauma#1
12:48 - 12:53
Discussion
12:53 - 12:57
Trauma#2
12:57 - 13:02
Discussion
BRAVS ROOM
13:02 - 14:02
Lunch Symposium

LUNCH SYMPOSIUM ROCHE: BEYOND VEGF: TARGETING THE ANG–TIE PATHWAY FOR THE MANAGEMENT OF RETINAL DISEASES

13:02 - 13:04
Opening Roche
13:04 - 13:06
Opening
13:06 - 13:13
Unmet need
13:13 - 13:20
Role of Ang2 in retinal vascular diseases
13:20 - 13:27
What's new? Innovation perspective
13:27 - 13:45
Discussion
13:45 - 13:47
Conclusion
BRAVS ROOM
14:02 - 14:29
International Lecture

INTERNATIONAL LECTURES 04

14:02 - 14:11
The Role of Mitochondrial Genetics in Retinal Diseases
14:11 - 14:20
Intraocular Lymphoma
14:20 - 14:29
Surgery for Infectious Retinitis when Medical Therapy is not sufficient
BRAVS ROOM
14:29 - 15:41
Panel

BRAVS PANEL 03 – MEDICAL RETINA

14:29 - 14:33
Posterior uveitis#1
14:33 - 14:38
Discussion
14:38 - 14:42
Posterior uveitis#2
14:42 - 14:47
Discussion
14:47 - 14:51
Posterior uveitis#3
14:51 - 14:56
Discussion
14:56 - 15:00
Posterior uveitis#4
15:00 - 15:05
Discussion
15:05 - 15:09
Posterior Uveitis#5
15:09 - 15:14
Discussion
15:14 - 15:18
Ocular oncology#1
15:18 - 15:23
Discussion
15:23 - 15:27
Ocular oncology#2
15:27 - 15:32
Discussion
15:32 - 15:36
Ocular oncology#3
15:36 - 15:41
Discussion
BRAVS ROOM
15:41 - 16:11
Break

BREAK

BRAVS ROOM
16:11 - 16:38
International Lecture

INTERNATIONAL LECTURES 05

16:11 - 16:20
Predictors of Post- Injection Endophthalmitis
16:20 - 16:29
Diabetic Vitrectomy: My current techniques
16:29 - 16:38
Beyond 400 microns macular holes: Surgical Algorithm based on the CLOSE Study Group data
BRAVS ROOM
16:38 - 17:50
Panel

BRAVS PANEL 04 – SURGICAL RETINA

16:38 - 16:42
Macular surgery#1
16:42 - 16:47
Discussion
16:47 - 16:51
Macular Surgery#2
16:51 - 16:56
Discussion
16:56 - 17:00
Retinal detachment#1
17:00 - 17:05
Discussion
17:05 - 17:09
Retinal detachment#2
17:09 - 17:14
Discussion
17:14 - 17:18
Diabetic vitrectomy#1
17:18 - 17:23
Discussion
17:23 - 17:27
Diabetic vitrectomy#2
17:27 - 17:32
Discussion
17:32 - 17:36
Complication#1
17:36 - 17:41
Discussion
17:41 - 17:45
Complication#2
17:45 - 17:50
Discussion
BRAVS ROOM
17:50 - 18:17
Symposium

IJRV Symposium

17:50 - 17:59
History and development
17:59 - 18:08
Publishers perspective
18:08 - 18:17
Discussion and awards
BRAVS ROOM
08:00 - 08:29
Bravs Lecture

BRAVS LECTURE 02

08:05 - 08:29
Vitreoretinal Surgery: Improving results and preventing complications
BRAVS ROOM
08:29 - 08:56
International Lecture

INTERNATIONAL LECTURES 06

08:29 - 08:38
Recurrent Diabetic Macular Edema. What to do?
08:38 - 08:47
Update on Pachychoroid
08:47 - 08:56
27G Vitrectomy Advantages
BRAVS ROOM
08:56 - 10:08
Debate

BRAVS DEBATE

08:56 - 08:59
ROP - Laser / Crio
08:59 - 09:02
ROP - Anti VEGF
09:02 - 09:05
Discussion
09:05 - 09:08
Risk / Benefit Ratio for Brolucizumab Is acceptable:
09:08 - 09:11
Risk / Benefit Ratio for Brolucizumab Is not acceptable:
09:11 - 09:14
Discussion
09:14 - 09:17
CI-DME. AntiVEGF
09:17 - 09:20
CI-DME. Steroids
09:20 - 09:23
Discussion
09:23 - 09:26
PDR. AntiVEGF
09:26 - 09:29
PDR. PRP
09:29 - 09:32
Discussion
09:32 - 09:35
Primary Rhegmatogenous RD: SB / PR
09:35 - 09:38
Primary Rhegmatogenous RD: PPV
09:38 - 09:41
Discussion
09:41 - 09:44
Symptomatic Floaters: Observation
09:44 - 09:47
Symptomatic Floaters: Floaterectomy
09:47 - 09:50
Discussion
09:50 - 09:53
Myopic Foveoschisis: Observation:
09:53 - 09:56
Myopic Foveoschisis: PPV
09:56 - 09:59
Discussion
09:59 - 10:02
Large Macular Hole: Conventional ILM Peeling
10:02 - 10:05
Large Macular Hole: New Options
10:05 - 10:08
Discussion
BRAVS ROOM
10:08 - 10:38
Break

BREAK

BRAVS ROOM
10:38 - 11:05
International Lecture

INTERNATIONAL LECTURES 07

10:38 - 10:47
Retinal Imaging in Alzheimer's Disease:Hype or Breakthrough?
10:47 - 10:56
Artificial Intelligence to Explore New Biomakers in AMD
10:56 - 11:05
Artificial Intelligence using Ultra-Wide Field Imaging in the diagnostic of Retinal Disease
BRAVS ROOM
11:05 - 12:26
Symposium

BRAVS Imaging Symposium

11:05 - 11:14
Mystery Case
11:14 - 11:23
Mystery Case
11:23 - 11:32
Mystery Case
11:32 - 11:41
Mystery Case
11:41 - 11:50
Mystery Case
11:50 - 11:59
Mystery Case
11:59 - 12:08
Mystery Case
12:08 - 12:17
Mystery Case
12:17 - 12:26
Mystery Case
BRAVS ROOM
12:26 - 13:26
Lunch Symposium

LUNCH SYMPOSIUM ROCHE: LONGER-ACTING THERAPIES: OPTIMISING nAMD MANAGEMENT

12:26 - 12:28
Opening Roche
12:28 - 12:30
Welcome and opening remarks
12:30 - 12:33
Addressing the unmet need for longer-acting therapies for nAMD
12:33 - 12:36
Continuous delivery of anti–VEGF-A
12:36 - 12:44
PDS Surgery Story
12:44 - 12:54
Phase 3 data
12:54 - 13:09
Panel discussion
13:09 - 13:11
Conclusion
BRAVS ROOM
13:26 - 13:53
International Lecture

INTERNATIONAL LECTURES 08

13:26 - 13:35
Repair that Retina: A Novel Educational Platform in Surgical Retina
13:35 - 13:44
Epiretinal Membranes: New Classification.New Concepts
13:44 - 13:53
AI for Retina - Sunshine or Storm?
BRAVS ROOM
13:53 - 15:08
Medical Case

BRAVS MEDICAL CASE 01

13:53 - 13:56
Mystery case
13:56 - 13:58
Discussion
13:58 - 14:01
Mystery case
14:01 - 14:03
Discussion
14:03 - 14:06
Mystery case
14:06 - 14:08
Discussion
14:08 - 14:11
Mystery case
14:11 - 14:13
Discussion
14:13 - 14:16
Mystery case
14:16 - 14:18
Discussion
14:18 - 14:21
Mystery case
14:21 - 14:23
Discussion
14:23 - 14:26
Mystery case
14:26 - 14:28
Discussion
14:28 - 14:31
Mystery case
14:31 - 14:33
Discussion
14:33 - 14:36
Mystery case
14:36 - 14:38
Discussion
14:38 - 14:41
Mystery case
14:41 - 14:43
Discussion
14:43 - 14:46
Mystery case
14:46 - 14:48
Discussion
14:53 - 14:56
Mystery case
14:56 - 14:58
Discussion
14:58 - 15:01
Mystery case
15:01 - 15:03
Discussion
15:03 - 15:06
Mystery case
15:06 - 15:08
Discussion
BRAVS ROOM
15:08 - 15:38
Break

BREAK

BRAVS ROOM
15:38 - 16:05
International Lecture

INTERNATIONAL LECTURES 09

15:38 - 15:47
Simple Method to avoid subretinal PCFL in Retina Detachment
15:47 - 15:56
Management of Pediatric Genetic Retinal Detachment
15:56 - 16:05
Update on the Port Delivery System
BRAVS ROOM
16:05 - 17:20
Medical Case

BRAVS MEDICAL CASE 02

16:05 - 16:08
Mystery case
16:08 - 16:10
Discussion
16:10 - 16:13
Mystery case
16:13 - 16:15
Discussion
16:15 - 16:18
Mystery case
16:18 - 16:20
Discussion
16:20 - 16:23
Mystery case
16:23 - 16:25
Discussion
16:25 - 16:28
Mystery case
16:28 - 16:30
Discussion
16:30 - 16:33
Mystery case
16:33 - 16:35
Discussion
16:35 - 16:38
Mystery case
16:38 - 16:40
Discussion
16:40 - 16:43
Mystery case
16:43 - 16:45
Discussion
16:45 - 16:48
Mystery case
16:48 - 16:50
Discussion
16:50 - 16:53
Mystery case
16:53 - 16:55
Discussion
16:55 - 16:58
Mystery case
16:58 - 17:00
Discussion
17:00 - 17:03
Mystery case
17:03 - 17:05
Discussion
17:05 - 17:08
Mystery case
17:08 - 17:10
Discussion
17:10 - 17:13
Mystery case
17:13 - 17:15
Discussion
17:15 - 17:18
Mystery case
17:18 - 17:20
Discussion
BRAVS ROOM
17:20 - 17:50
Symposium

PRO.VER Social

17:20 - 17:26
O que é a PRO.VER?
17:26 - 17:32
Oportunidades de ações da Pro.Ver: modelos de iniciativas
17:32 - 17:38
Perspectivas de potencialização dos mutirões diabéticos
17:38 - 17:44
Programas de acesso aos pacientes carentes para terapia com antiangiogênicos
17:44 - 17:50
Discussão
BRAVS ROOM
17:50 - 18:00
Closing Ceremony

CLOSING CEREMONY